Werbung ausblenden
Aktie • Biotechnologie

CYMABAY THERAPEUTICS

WKN
ISIN
Ticker
•
WKN
Ticker
•
ISIN
Tagesspanne
–
52W-Spanne
–
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
theScreener Rating
–
Nachhaltigkeits-Score
–

Unternehmens­daten

Stammdaten zu CYMABAY THERAPEUTICS

WKN
A116DD
ISIN
US23257D1037
Home-Symbol
CBAY
Symbol
C0I
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Anteilseigner

Avoro Capital Advisor LLCBlackRock Fund AdvisorsRA Capital Management LPJanus Henderson Investors US LLCThe Vanguard Group, Inc.T. Rowe Price Associates, Inc. (Investment Management)Perceptive Advisors LLCJennison Associates LLCFranklin Advisers, Inc.Holocene Advisors, LPSSgA Funds Management, Inc.Octagon Capital Advisors LPAdage Capital Management LPPoint72 Asset Management LPGeode Capital Management LLCFidelity Management & Research Co. LLCFred Alger Management LLCCormorant Asset Management LPForesite Capital Management LLCVestal Point Capital LP
  • Avoro Capital Advisor LLC (9,68 %)
  • BlackRock Fund Advisors (7,57 %)
  • RA Capital Management LP (6,05 %)
  • Janus Henderson Investors US LLC (5,28 %)
  • The Vanguard Group, Inc. (5,24 %)
  • T. Rowe Price Associates, Inc. (Investment Management) (3,81 %)
  • Perceptive Advisors LLC (3,51 %)
  • Jennison Associates LLC (3,48 %)
  • Franklin Advisers, Inc. (2,83 %)
  • Holocene Advisors, LP (2,61 %)

Kontakt

Werbung ausblenden